xanomeline has been researched along with Blood Poisoning in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Abed, Y; Chavan, SS; Cheng, KF; Dancho, ME; Katz, D; Ochani, M; Olofsson, PS; Pavlov, VA; Rosas-Ballina, M; Tracey, KJ; Valdés-Ferrer, SI | 1 |
| Steinman, L | 1 |
2 other study(ies) available for xanomeline and Blood Poisoning
| Article | Year |
|---|---|
Xanomeline suppresses excessive pro-inflammatory cytokine responses through neural signal-mediated pathways and improves survival in lethal inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Illness Behavior; Injections, Intraperitoneal; Lipopolysaccharides; Male; Mice, Inbred BALB C; Muscarinic Agonists; Pyridines; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Sepsis; Spleen; Survival Analysis; Thiadiazoles; Tumor Necrosis Factor-alpha; Vagotomy; Vagus Nerve | 2015 |
A century of pavlovian experiments forming a circuit from the elucidation of neural reflexes to pharmaceuticals and electroceuticals to treat diseases.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Male; Muscarinic Agonists; Pyridines; Sepsis; Spleen; Thiadiazoles; Vagus Nerve | 2015 |